May/June 2013



Epilepsy: Now and in the Future

New drugs continue to offer hope to patients, as research seeks other ways to optimize care.

By Zac Haughn, Senior Associate Editor

The Epilepsy Pipeline

In any disorder, the pipeline is the lifeblood of patients’ and physicians’ hopes for more promising care and better results. And epilepsy’s pipeline has several drugs worth keeping an eye on.

By Zac Haughn, Senior Associate Editor

Autologous Umbilical Cord Blood Treatment for Autism: Rationale and Potential Goals of Treatment

Could autologous umbilical cord blood (AUCB) offer stem cells that could alter functionality of aberrant immune or nervous system cells affected by some environmental factor in patients with negative genetic screening for autism?

By Michael G. Chez, MD


Bionic Breakout: Robotic-Assisted Therapy Is Evolving

Robotic-assisted therapy has made significant strides in the past 15 years. Will it overtake conventional physical therapy?

By Zac Haughn, Senior Associate Editor

In the Pipeline: Nasal Oxytocin Explored for Migraines

Can migraine patients trust the “trust drug” to heal their pain?

A Q&A with David C. Yeomans, PhD

Online Preview

Emerging Research Can Aid Therapeutic Development

Previews of exclusive online content from


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.